by Bay Biosciences | Apr 30, 2023 | News Releases
Bay Biosciences provides high quality, clinical grade, cryogenically preserved sera (serum) and matched K3-EDTA plasma and stool specimens from non-alcoholic fatty liver disease (NAFLD) patients. The sera (serum) and K3-EDTA plasma specimens are processed from...
by Bay Biosciences | Apr 23, 2023 | News Releases
Bay Biosciences provides high-quality biopsy tissue samples, formalin fixed paraffin embedded (FFPE) tissue blocks, with matched frozen sera (serum), plasma, and peripheral blood mononuclear cells (PBMC) bio-fluids, from patients diagnosed with ulcerative colitis....
by Bay Biosciences | Apr 14, 2023 | News Releases
Bay Biosciences provides high quality, clinical grade, cryogenically preserved sera (serum) and matched K3-EDTA plasma specimens from shingles-varicella-zoster virus (VZV) positive patients. The sera (serum) and K3-EDTA plasma specimens are processed from...
by Bay Biosciences | Apr 10, 2023 | News Releases
Bay Biosciences provides high quality, clinical grade, cryogenically preserved sera (serum) and matched K3-EDTA plasma specimens from hepatitis-C (Hep-C) virus positive patients. The sera (serum) and K3-EDTA plasma specimens are processed from hepatitis-C...
by Bay Biosciences | Apr 5, 2023 | News Releases
Bay Biosciences provides high quality, clinical grade, cryogenically preserved sera (serum) and matched K3-EDTA plasma specimens from COVID-19 (coronavirus) SARS-CoV-2 positive patients. The sera (serum) and K3-EDTA plasma specimens are processed from COVID-19...
by Bay Biosciences | Mar 30, 2023 | News Releases
Bay Biosciences provides high quality, clinical grade, cryogenically preserved sera (serum) and matched K3-EDTA plasma specimens from Parkison’s disease (PD) patients. The sera (serum) and K3-EDTA plasma specimens are processed from Parkinson’s disease...
